SQSTM1 and malignant pleural mesothelioma: Hegedüs et al. reported that dasatinib increased the autophagic flux, as assessed by the degradation of the autophagy substrate p62/SQSTM1 and increased levels of LC3II, an increased number of GFP-LC3 puncta, and decreased readings of the luminescence of the HiBiT-LC3 reporter in different malignant pleural mesothelioma cells.